Tag Archives: The Stem Cell Blog

SGI-DNA Sees Deal with Belgium’s VIB as Springboard to Building European Synthetic Genomics Business
GenomeWeb
“Europe is a very large market for synthetic biology and we see particular promise in Belgium, Germany, France, Switzerland, and the UK,” Wood said. “From our perspective, research is advancing in these areas as the governments invest in research into …

SGI-DNA Sees Deal With Belgium’s VIB as Springboard to Building European Synthetic Genomics Business
GenomeWeb
“Europe is a very large market for synthetic biology and we see particular promise in Belgium, Germany, France, Switzerland, and the UK,” Wood said. “From our perspective, research is advancing in these areas as the governments invest in research into …

Boosting immune cell memory to improve vaccines and cancer …
Science Daily
Drugs that activate the cells’ proteasome, or recycling center, tip the balance in favor of memory CD8+ T cells, studies on mice show. This approach could be …

and more »

Being for the $11.9bn benefit of investors of Kite: Gilead jumps into CAR T
BioPharma-Reporter.com
Gilead will also add a chimeric antigen receptor (CAR) T-cell manufacturing facility in El Segunda, California which opened in June last year and has the capacity to produce volumes of the autologous therapy for up to 4,000-5,000 patients per year.
Gilead agrees to buy Kite Pharma, leaping into CAR–T cancer therapySTAT
Gilead’s Plan? Cash In on CAR–TMotley Fool
Gilead just handed a revolutionary kind of cancer treatment a $12 billion endorsementBusiness Insider
Barron’s –Xconomy –Zacks Investment Research
all 333 news articles »

Being for the $11.9bn benefit of investors of Kite: Gilead jumps into CAR T
BioPharma-Reporter.com
Gilead will also add a chimeric antigen receptor (CAR) T-cell manufacturing facility in El Segunda, California which opened in June last year and has the capacity to produce volumes of the autologous therapy for up to 4,000-5,000 patients per year.
Gilead agrees to buy Kite Pharma, leaping into CAR–T cancer therapySTAT
Gilead’s Plan? Cash In on CAR–TMotley Fool
Gilead just handed a revolutionary kind of cancer treatment a $12 billion endorsementBusiness Insider
Barron’s –Xconomy –Zacks Investment Research
all 333 news articles »

Newly approved CAR–T therapy could mark breakthrough in cancer treatments
Genetic Literacy Project
Carl H. June, MD, is a professor of immunology at the University of Pennsylvania Perelman School of Medicine. He developed what is known as Chimeric Antigen Receptor T–cell therapy (CAR-T) which is an engineered version of a patient’s T–cells to …

Researchers discover new immunotherapy combination effective at killing cancer cells
Medical Xpress
Immunotherapy is an emerging field in the global fight against cancer, even though scientists and clinicians have been working for decades to find ways to help the body’s immune system detect and attack cancerous cells. Doug Mahoney’s lab at the …
New treatment eradicates cancer cells in Glasgow University studyBBC News
Glasgow university scientists find new method of killing cancer cellsThe Times
Anti-cancer breakthrough CICD can eradicate tumours, researchers saySky News

all 15 news articles »